Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today reported that the Company has delivered its first shipment of QS-B220 desktop Explosives Trace Detectors (ETDs) to airports across the United States.
These units are a part of the 1,170 unit order that was placed by the Transportation Security Administration (TSA) in November, 2014. The entirety of the 1,170 units is expected to be delivered across more than 40% of airports in the United States within Implant Sciences' fiscal year 2016, which began July 1, 2015.
"We are pleased to accommodate TSA's preferred delivery schedule for this shipment. As an American company, the fact that our QS-B220 ETDs are being deployed across the United States and will provide valuable protection to passengers represents the accomplishment of a major milestone," stated Todd Swearingen, General Manager, Americas. "Implant Sciences is honored to have been selected by TSA and we look forward to enhancing security operations across U.S. airports. This has been an important goal for the company for many years now, and we are extremely proud of this success."
About the QS-B220 Desktop Explosives Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.